Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Cardiovascular comorbidity in psoriasis - psoriatic inflammation is more than just skin deep
Katharina S Kommoss1,2, Alexander Enk1, Mathias Heikenwälder2
1Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
Insights
Psoriasis involves systemic inflammation, increasing cardiovascular risk. Managing comorbidities is crucial for patients, requiring interdisciplinary care to address vascular inflammation and heart disease.
Area of Science:
- Dermatology
- Cardiology
- Immunology
Background:
- Psoriasis is increasingly understood as a systemic inflammatory condition, not just a skin disease.
- Guidelines recommend managing comorbidities like metabolic and cardiovascular diseases in psoriasis patients.
- Psoriasis is now recognized by cardiologists as a risk factor for cardiovascular inflammation.
Purpose of the Study:
- To review epidemiological, mechanistic, and management aspects of psoriasis and its comorbidities.
- To contextualize findings for physicians treating psoriasis patients.
- To highlight interdisciplinary care efforts for vascular inflammation and cardiovascular disease in psoriasis.
Main Methods:
- Literature review was conducted.
- Key findings on epidemiology, mechanisms, and management were summarized.
Main Results:
- Research is ongoing to understand the mechanisms of systemic inflammation in psoriasis.
- Studies on treating cardiovascular comorbidities with dermatological therapies show mixed results.
- Diagnosing psoriasis has implications for preventing and treating associated diseases.
Conclusions:
- Understanding psoriasis comorbidities necessitates interdisciplinary patient care.
- This article focuses on advancements in managing vascular inflammation and cardiovascular disease in psoriasis patients.
Background:
There is a growing understanding of inflammation in psoriasis beyond its dermatological manifestation, towards systemic inflammation. Management of possible comorbidities encompassing psychological, metabolic and cardiovascular disease is recommended in national and international dermatology guidelines for treatment of psoriasis patients. Vice versa, psoriasis is being recognized as a new risk factor for cardiovascular inflammation within the cardiological community.
Methods:
A review of the literature was conducted. Key points regarding epidemiological, mechanistic and management aspects were summarized and put into context for physicians treating psoriasis patients.
Results:
Efforts are currently being made to better understand the mechanistic underpinnings of systemic inflammation within psoriatic inflammation. Studies looking to "hit two birds with one stone" regarding specifically cardiovascular comorbidities of psoriasis patients using established systemic dermatological therapies have so far provided heterogeneous data. The diagnosis of psoriasis entails preventive and therapeutic consequences regarding concomitant diseases for the individual patient.
Conclusions:
The knowledge of comorbidities in psoriasis calls for pronounced interdisciplinary care of psoriasis patients, to which this article highlights efforts regarding vascular inflammation and cardiovascular disease.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease I: Introduction

